×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [current analysis plan]
Home >
current analysis plan
First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone.
214 views